Though ischemic outcomes numerically favored the Amulet, confirmation in future studies is needed, experts say.

The drug was approved last year for patients with hypertension currently not controlled on other BP-lowering agents.

David Ferreira talks to C. Michael Gibson about the latest data showing patients don't need to fast ahead of cardiac ...

The transition from adolescence can bring decreased physical activity, a worse diet, and little focus on overall CV health.